Husband, Father, Son | Senior Vice President of Public Affairs @PhRMA | Fan of @Nationals & @PGATour
Washington D.C.
Joined May 2009
- Tweets846
- Following3K
- Followers7.7K
- Likes13.4K
Alex Schriver retweeted
ICYMI: A federal judge granted PhRMA other drugmakers’ request to intervene in a lawsuit over the 340B rebate pilot program, pivoting from a previous decision denying their involvement. news.bloomberglaw.com/health…
Alex Schriver retweeted
Certain people love posting the Young Guns cover, now they can post this.
October 2007: Three backbench Members of Congress take the photo, launch the brand, and build momentum.
Two Speakers. One VP Nominee; Chairman of Ways and Means. Two Majority Leaders. Two Whips. Largest landslide election win since 1946.
Not bad for three rank-and-file Members.
#DealWithIt
Zooming in on Huntsville's biotech boom axios.com/local/huntsville/2…
Alex Schriver retweeted
Huntsville’s biotech future is bright 🚀
Thank you to @Axios and everyone who joined for Beyond the Breakthrough! There were great conversations on the Rocket City’s biotech rise, and how Huntsville is bringing more medicine manufacturing home and building the workforce to power it.
Alex Schriver retweeted
Axios’ Beyond the Breakthrough: Huntsville’s Biotech Rise xitter.cf/i/broadcasts/1vJpPNebv…
Alex Schriver retweeted
New @HHS_ASPE report: Mission vs. Margin: Misaligned Incentives in the 340B Drug Pricing Program
aspe.hhs.gov/reports/misalig…
h/t Aiden Lee, Khrysta Dunkel @KhrystaDunkel, Eden Volkov, Sebastian Askar, @caseybmulligan
@HHSGov @CMSGov @HHSResponse
Alex Schriver retweeted
“A small, well-intended discount for safety net hospitals became a large institutional subsidy with expensive unintended consequences,” writes an HHS leader. trib.al/hexZCg4
Alex Schriver retweeted
PhRMA Report Slams 340B Program for Boosting Hospital Profits news.bgov.com/bloomberg-gove…
Alex Schriver retweeted
“The surest way to secure our biotech lead is to build up our own capabilities,” write Gary Locke and Patrick McHenry. trib.al/qvl91Mz
Alex Schriver retweeted
I had the honor of serving in Congress with Eric Cantor, and am grateful to see him back in the policy arena - incisive, strategic and a damn hard worker. Excited for his work ahead and the innovation he will bring to industry. @EricCantor @PhRMA
Eric Cantor, former House leader, named PhRMA president and CEO axios.com/2026/09/29/eric-ca…
Alex Schriver retweeted
Congratulations to Eric Cantor on being named the next president and CEO of @PhRMA. Everyone who worked with Eric on the Hill saw his leadership firsthand. No one works harder. Honored to call him a friend.
We are excited to announce Eric Cantor as our next president and CEO.
Eric is well respected among policy leaders in Washington and around the world, with a long track record of working effectively across the political spectrum in support of biomedical research and patients’ access to medicines. He joins PhRMA at a pivotal moment for America’s biopharmaceutical industry.
Read more: phrma.org/resources/phrma-se…
Alex Schriver retweeted
No other way to say it, Eric Cantor is simply the best.
This is tremendous news for the industry, but more importantly for the millions of people who rely on the life saving and life improving inventions of pharmaceutical companies
We are excited to announce Eric Cantor as our next president and CEO.
Eric is well respected among policy leaders in Washington and around the world, with a long track record of working effectively across the political spectrum in support of biomedical research and patients’ access to medicines. He joins PhRMA at a pivotal moment for America’s biopharmaceutical industry.
Read more: phrma.org/resources/phrma-se…
Alex Schriver retweeted
Great news for our industry and for patients, welcome @EricCantor - and my thanks to @steveubl for over a decade of strong leadership championing American innovation.
We are excited to announce Eric Cantor as our next president and CEO.
Eric is well respected among policy leaders in Washington and around the world, with a long track record of working effectively across the political spectrum in support of biomedical research and patients’ access to medicines. He joins PhRMA at a pivotal moment for America’s biopharmaceutical industry.
Read more: phrma.org/resources/phrma-se…
ICYMI: PhRMA Selects Eric Cantor to Lead Organization as Next President and CEO
phrma.org/resources/phrma-se…
Alex Schriver retweeted
We are excited to announce Eric Cantor as our next president and CEO.
Eric is well respected among policy leaders in Washington and around the world, with a long track record of working effectively across the political spectrum in support of biomedical research and patients’ access to medicines. He joins PhRMA at a pivotal moment for America’s biopharmaceutical industry.
Read more: phrma.org/resources/phrma-se…
Alex Schriver retweeted
Eric Cantor, former House leader, named PhRMA president and CEO axios.com/2026/09/29/eric-ca…
Alex Schriver retweeted
🧪 PA is a life sciences powerhouse!
Great to join @Axios and @PhRMA in Philadelphia to talk about how our state’s biotech industry is leading on innovation and creating the next generation of companies and cures.
Pennsylvania's life sciences industry is booming, and it's no accident.
Strategic leadership decisions have made the Commonwealth one of the most attractive places in the country to invest and biopharmaceutical companies are responding with major investments that bring huge economic benefits to the community.
And they're just getting started. ow.ly/KXGl50ZPTcX
Alex Schriver retweeted
New polling from @votersforcures and @MorningConsult: Voters prefer a candidate with a real plan to lower health insurance premiums.
Voters want reforms that lower costs and hold insurers accountable – not policies that threaten innovation and access to medicines. ow.ly/hs0n50ZP7nK
